M. E. C. Devolder et al., “CLINICAL OUTCOMES OF LONG-TERM USE OF SGLT2 INHIBITORS IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE”, REASE, vol. 10, no. 8, pp. 2042–2052, Aug. 2024, doi: 10.51891/rease.v10i8.15327.